Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
Other Names :
Dexamethasone corticosteroid |
|||
Identifiers & Properties | ||||
CAS Number | 2392-39-4 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 22 H 28 FNa 2O 8P | RS Single Impurity: RS Total Impurity: |
NMT-0.5 % NMT-1.0 % |
|
Molar mass | 392.467 g·mol−1 | HPLC : | NLT 99.0 % | |
Specific Optical Rotation: | +72.0° to +80.0° | Assay By HPLC: | 96.0% to 104.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
Other Names :
Hexadrol Phosphate |
|||
Identifiers & Properties | ||||
CAS Number | 50-02-2 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 22 H 29 FO 5 | RS Total Impurity: | NMT - 1.0 % | |
Molar mass | 516.4 g·mol−1 | HPLC : | NLT 99.0 % | |
Specific Optical Rotation: | +75.0° to +83.0° | Assay By HPLC: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- 3H-cyclopenta[a]phenanthren-3-one |
Other Names :
Betamethasonum |
|||
Identifiers & Properties | ||||
CAS Number | 378-44-9 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 22 H 29 FO 5 | RS Total Impurity: | NMT - 2.0 % | |
Molar mass | 392.46 g·mol−1 | HPLC : | NLT 98.0 % | |
Specific Optical Rotation: | +118.0° to +126.0° | Assay | 96.0% to 104.0% | |
Pharmacology | ||||
Routes of administration | By mouth, topical, intramuscular |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
Disodium; [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate |
Other Names :
Betamethasone 21-phosphate disodium |
|||
Identifiers & Properties | ||||
CAS Number | 151-73-5 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 22 H 28 FNa 2 O 8 P | RS Total Impurity: | NMT - 3.0 % | |
Molar mass | 516.4 g/mol | HPLC : | NLT 97.0 % | |
Specific Optical Rotation: | +98.0° to + 104.0° | Assay By HPLC: | 96.0% to 103.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
[17-(2'-Chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate |
Other Names :
Clobetasol 17-propanoate |
|||
Identifiers & Properties | ||||
CAS Number | 25122-46-7 | Appearance: Odour: |
A White or almost white powder, crystalline powder Odourless Powder |
|
Chemical formula | C 25 H 32 CIFO 5 | RS Total Impurity: | NMT - 2.0 % | |
Molar mass | 466.97 g·mol−1 | HPLC : | NLT 98.0 % | |
Specific Optical Rotation: | +112.0° to + 118.0° | Assay By HPLC: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
(16β)-21-Chloro-9-fluoro-16-methyl-3,11,20-trioxopregna-1,4-dien-17-yl butyrate |
Other Names : Clobetasone 17-butyrate |
|||
Identifiers & Properties | ||||
CAS Number | 25122-57-0 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 26 H 32 CIFO 5 | RS Single Impurity: RS Total Impurity: |
NMT - 0.1 % NMT - 0.5% |
|
Molar mass | 478.99 g·mol−1 | HPLC : | NLT 99.5 % | |
Specific Optical Rotation: | +131.0° to + 138.0° | Assay By UV: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate |
Other Names : mometasone 17-furoate, Mometasone furoate anhydrous |
|||
Identifiers & Properties | ||||
CAS Number | 83919-23-7 | Appearance: Odour: |
A White or almost white powder Odourless Powder |
|
Chemical formula | C 27 H 30 CI 2 O 6 | RS Total Impurity: | NMT - 0.3 % | |
Molar mass | 521.43 g·mol−1 | HPLC : | NLT 99.4 % | |
Specific Optical Rotation: | +50.0° to + 55.0 | Assay By HPLC: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth, sublingual, injection, Drops, spray. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
(11β,16β)-21-(Acetyloxy)-11-hydroxy-2′-methyl-5′H-pregna-1,4-dieno[17,16-d] oxazole-3,20-dione |
Other Names : Deflazacort |
|||
Identifiers & Properties | ||||
CAS Number | 14484-47-0 | Appearance: Odour: |
White to creamy white crystalline powder | |
Chemical formula | C 25 H 31 NO 6 | RS Total Impurity: | NMT - 2.0 % | |
Molar mass | 441.52 g·mol−1 | HPLC : | NLT 98.0 % | |
Specific Optical Rotation: | +57.0° to + 65.0° | Assay By HPLC: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
6α-Methylprednisolone; 11β,17,21-trihydroxy-6α-methyl-δ-progesterone; 11β,17,21-Trihydroxy-6α-methylpregna-1,4-diene-3,20-dione |
Other Names : 11β,17,21-trihydroxy-6α-methylpregna-1,4-diene-3, 20-dione |
|||
Identifiers & Properties | ||||
CAS Number | 83-43-2 | Appearance: Odour: |
A white or almost white, crystalline powder. | |
Chemical formula: | C 22 H 30 O 5 | RS Total Impurity: | NMT 2.0 % | |
Molar mass: | 374.5 g·mol−1 | HPLC : | NLT 98.0 % | |
Specific Optical Rotation: | +79.0° to +86.0° | Assay By HPLC: | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | By mouth, intramuscular, intra-articular, intravenous |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid |
Other Names : Methylprednisolone 21-succinate sodium salt |
|||
Identifiers & Properties | ||||
CAS Number | 2375-03-3 | Appearance: Odour: |
White or nearly white, odourless, hygroscopic, amorphous solid Powder | |
Chemical formula | C 26 H 33 NaO 8 | Specific Optical Rotation : | +96.0° to + 104.0° | |
Molar mass | 496.5 g·mol−1 | Assay : | 97.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | Intravenous, intramuscular injection. |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name :
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate |
Other Names : Latanoprost (isopropyl ester) |
|||
Identifiers & Properties | ||||
CAS Number | 130209-82-4 | Appearance: | Clear, colourless or yellow, viscous, oily liquid | |
Chemical formula | C 26 H 40 O 5 | Specific Optical Rotation: | +31.0° to +38.0° | |
Molar mass | 432.6 g·mol−1 | Assay: | 94.0% to 102.0% | |
Pharmacology | ||||
Routes of administration | Topical eye drops |
Names | ||||
---|---|---|---|---|
Preferred IUPAC Name:
(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-5-heptenamide |
Other Names: Bimatoprost |
|||
Identifiers & Properties | ||||
CAS Number | 155206-00-1 | Appearance: | White or almost white powder | |
Chemical formula | C 25 H 37 NO 4 | Residue on Ignition: | NMT 0.2 % | |
Molar mass | 415.6 g·mol−1 | HPLC: | Total Impurities: NMT 1.0 % | |
Specific Optical Rotation: | +33.0° to +39.0° | Assay: | 97.0% to 101.0% | |
Pharmacology | ||||
Routes of administration | Eye drops |